// App-Quantinova.ai

O36 : Exploring NICE criteria for continuing biologic therapies in axial spondyloarthritis: what is a suboptimal response?

Researchers

Presenter

  • Fariz Yahya

Principal Investigators

  • Karl Gaffney

  • Raj Sengupta

Medical Centers

  • Medicine, University Malaya Medical Centre, Kuala Lumpur, MALAYSIA

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

  • Paediatrics, Norfolk and Norwich University Hospitals NHS Foundation Trust,Norwich, United Kingdom

  • Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom

Locations

  • Malaysia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved